112 related articles for article (PubMed ID: 8102221)
1. Proliferating cell nuclear antigen immunoreactivity in cervical intraepithelial neoplasia and benign cervical epithelium.
Shurbaji MS; Brooks SK; Thurmond TS
Am J Clin Pathol; 1993 Jul; 100(1):22-6. PubMed ID: 8102221
[TBL] [Abstract][Full Text] [Related]
2. Proliferation profile of benign and premalignant cervical epithelium as established by PCNA staining pattern.
Boon ME; Luzzatto R; Beck S; Bosch MM; Hermans J; Rietveld WJ
Pathol Res Pract; 1994 Apr; 190(4):372-7. PubMed ID: 7915836
[TBL] [Abstract][Full Text] [Related]
3. [Comparative study of HPV infection and proliferating cell nuclear antigen of uterine cervix].
Murakami T; Nagai N; Ota S; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):967-72. PubMed ID: 8103785
[TBL] [Abstract][Full Text] [Related]
4. Proliferative activity in cervical intraepithelial neoplasia and cervical carcinoma.
Xue Y; Feng Y; Zhu G; Zhang X
Chin Med J (Engl); 1999 Apr; 112(4):373-5. PubMed ID: 11593543
[TBL] [Abstract][Full Text] [Related]
5. The proliferative activity in dysplasia and carcinoma in situ of the uterine cervix analyzed by proliferating cell nuclear antigen immunostaining and silver-binding argyrophilic nucleolar organizer region staining.
Kobayashi I; Matsuo K; Ishibashi Y; Kanda S; Sakai H
Hum Pathol; 1994 Feb; 25(2):198-202. PubMed ID: 7907076
[TBL] [Abstract][Full Text] [Related]
6. Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change?
Barton SE; Maddox PH; Jenkins D; Edwards R; Cuzick J; Singer A
Lancet; 1988 Sep; 2(8612):652-4. PubMed ID: 2901519
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen (cyclin) expression in normal and abnormal cervical squamous epithelia.
Mittal KR; Demopoulos RI; Goswami S
Am J Surg Pathol; 1993 Feb; 17(2):117-22. PubMed ID: 8422109
[TBL] [Abstract][Full Text] [Related]
8. Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation.
Litvinov SV; van Driel W; van Rhijn CM; Bakker HA; van Krieken H; Fleuren GJ; Warnaar SO
Am J Pathol; 1996 Mar; 148(3):865-75. PubMed ID: 8774141
[TBL] [Abstract][Full Text] [Related]
9. Proliferation cell nuclear antigen (PCNA) expression in cervical intraepithelial neoplasia (CIN). An immunohistochemical study.
Smela M; Chosia M; Domagała W
Pol J Pathol; 1996; 47(4):171-4. PubMed ID: 9097708
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody MIB1 in the assessment of cervical squamous intraepithelial lesions.
McCluggage WG; Buhidma M; Tang L; Maxwell P; Bharucha H
Int J Gynecol Pathol; 1996 Apr; 15(2):131-6. PubMed ID: 8786202
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of metallothionein and MIB1 in uterine cervical squamous lesions.
McCluggage WG; Maxwell P; Bharucha H
Int J Gynecol Pathol; 1998 Jan; 17(1):29-35. PubMed ID: 9475189
[TBL] [Abstract][Full Text] [Related]
12. MIB 1 immunostaining in cervical intraepithelial neoplasia: prognostic significance in mild and moderate lesions.
Garzetti GG; Ciavattini A; De Nictolis M; Lucarini G; Goteri G; Romanini C; Biagini G
Gynecol Obstet Invest; 1996; 42(4):261-6. PubMed ID: 8979100
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of p53 oncoprotein and proliferating cell nuclear antigen (PCNA) in the cervix uteri.
Cardillo MR; Stamp GW; Pignatelli MN; Lalani EN
Eur J Gynaecol Oncol; 1993; 14(6):484-90. PubMed ID: 7910135
[TBL] [Abstract][Full Text] [Related]
14. [Cervix dysplasias: study of Rb and p53 gene expression and correlation with mitotic activity].
Mathevet P; Frappart L; Hittelman W
Gynecol Obstet Fertil; 2000 Jan; 28(1):44-50. PubMed ID: 10774117
[TBL] [Abstract][Full Text] [Related]
15. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.
Nagai N; Oshita T; Murakami J; Ohama K
Oncol Rep; 1999; 6(2):325-8. PubMed ID: 10022998
[TBL] [Abstract][Full Text] [Related]
16. Metaphase-arrest technique applied to human cervical epithelium. II. Cell production rates in normal and pathological cervical epithelium.
Ireland D
Cell Tissue Kinet; 1985 May; 18(3):321-31. PubMed ID: 3986873
[TBL] [Abstract][Full Text] [Related]
17. The evaluation of proliferative activity in CIN III and microinvasive cervical cancer and its role in recurrence.
Tjalma W; Weyler J; Pollefliet C; Bogers J; Van Marck E; van Dam P; Buytaert P
Eur J Obstet Gynecol Reprod Biol; 2001 Feb; 94(2):270-5. PubMed ID: 11165738
[TBL] [Abstract][Full Text] [Related]
18. Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion?
Brown LJ; Wells M
J Clin Pathol; 1986 Jan; 39(1):22-8. PubMed ID: 3950029
[TBL] [Abstract][Full Text] [Related]
19. Progressive dysregulation of proliferation during cervical carcinogenesis as measured by MPM-2 antibody staining.
Hu W; Mitchell MF; Boiko IV; Linares A; Kim HG; Malpica A; Tortolero-Luna G; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 1997 Sep; 6(9):711-8. PubMed ID: 9298579
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase pi is expressed in (pre) neoplastic lesions of the human uterine cervix irrespective of their degree of severity.
Martens JE; Smedts F; ter Harmsel B; Helmerhorst TJ; Ramaekers FC
Anticancer Res; 1997; 17(6D):4305-9. PubMed ID: 9494525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
